← All trials
NCT00755014
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2007
- Primary completion
- Mar 31, 2008
- Completion date
- Jul 31, 2008
- First posted
- Sep 18, 2008
- Last posted
- Sep 18, 2008
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Taipei Veteran General hospitalLead sponsor
- Taipei Veteran General hospitalOverall official - principal investigator
- Taipei Veteran General hospitalStudy director
- National Yang-Ming UniversityCollaborator
- National Yang Ming Chiao Tung University HospitalCollaborator
- Taipei Veteran General hospitalOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.